Durability of efficacy with selpercatinib in patients (pts) with RET fusion+ non-small-cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Drillon, A. E.; Subbiah, V.; Gautschi, O.; Tomasini, P.; De Braud, F. G.; Solomon, B.; Tan, D. S. W.; Alonso, G.; Wolf, J.; Park, K.; Goto, K.; Soldatenkova, V.; Szymczak, S.; Barker, S. S.; Puri, T.; Lin, A. K.; Loong, H.; Besse, B. |
| Abstract Title: | Durability of efficacy with selpercatinib in patients (pts) with RET fusion+ non-small-cell lung cancer (NSCLC) |
| Meeting Title: | 2022 Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 45 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Nov 13-16 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2022-11-01 |
| Start Page: | 149 |
| Language: | English |
| ACCESSION: | WOS:000883051700352 |
| PROVIDER: | wos |
| DOI: | 10.1159/000521004 |
| Notes: | Meeting Abstract: 255 -- Source: Wos |
